MYGN Operating Cash Flow
$7.70MTTM · USD
Period ending:
MYGN FY Operating Cash FlowUSD
$190.20M-$110.90M
1996-06-302025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
MYGN operating cash flow history
Cash generated from core business operations. The available annual fiscal periods series contains 31 observations from Jun 30, 1996 to Dec 31, 2025.
| Period ending | Operating Cash Flow (USD) |
|---|---|
| 1,800,000 | |
| -8,700,000 | |
| -110,900,000 | |
| -106,300,000 | |
| 18,600,000 | |
| -26,900,000 | |
| 60,700,000 | |
| 83,700,000 | |
| 115,900,000 | |
| 106,200,000 | |
| 166,300,000 | |
| 140,500,000 | |
| 190,200,000 | |
| 173,900,000 | |
| 141,804,000 | |
| 130,830,000 | |
| 155,086,000 | |
| 84,042,000 | |
| 103,736,000 | |
| -25,851,000 | |
| -28,027,000 | |
| -23,304,000 | |
| -30,880,000 | |
| -46,540,000 | |
| -16,312,043 | |
| -3,775,307 | |
| 17,163,535 | |
| -14,100,000 | |
| -7,000,000 | |
| -6,600,000 | |
| 1,400,000 |
Compare operating cash flow
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) operating cash flow
- Bridgebio Pharma Inc (BBIO) operating cash flow
- Brightspring Health Services Inc (BTSG) operating cash flow
- Madrigal Pharmaceuticals Inc (MDGL) operating cash flow
- Ensign Group Inc (ENSG) operating cash flow
- Glaukos Corp (GKOS) operating cash flow
- Vaxcyte Inc (PCVX) operating cash flow
- Krystal Biotech Inc (KRYS) operating cash flow
All MYGN financial metrics · MYGN stock overview · How to interpret financial metrics
